- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT06674863
국소성 또는 소수전이성 전립선암이 있는 흑인 또는 아프리카계 미국인 환자의 생존자 치료에 대한 이해와 접근성을 향상시키기 위한 맞춤형 생존자 치료 계획
소외된 아프리카계 미국인 전립선암 환자의 접근을 개선하기 위한 맞춤형 생존 관리 계획을 통해 건강 지식 문제 해결
This clinical trial compares the impact of a tailored survivorship care plan (SCP) to a standard SCP on the understanding of and access to survivorship care in black or African American patients with prostate cancer that has not spread to other parts of the body (localized) or that has spread from where it first started (primary site) to a limited number of places in the body (oligometastatic). SCPs summarize treatment history and recommendations for monitoring and maintaining health, and may also include potential long term effects of treatments received. The intention of a SCP is to help patients participate in their own health care. However, many patients have below basic levels of health literacy, meaning, they have a lower ability to obtain, communicate, process and understand basic health information and services to make health decisions. In fact, poor health literacy has been linked with worse quality of life in prostate cancer survivors. A tailored SCP includes the addition of an educational supplement based on lower reading and writing skills (low literacy) and may address health literacy barriers to understanding of treatment options and side effects. A standard SCP uses a template based on the American Society of Clinical Oncology (ASCO) guidelines for prostate cancer. A tailored SCP with low literacy educational supplements may be more effective compared to a standard SCP in improving understanding and access to survivorship care in black or African American patients with localized or oligometastatic prostate cancer.
연구 개요
상태
상세 설명
PRIMARY OBJECTIVES:
I. Compare outcomes after patients receive usual care from their providers with a standard SCP and after patients receive tailoring of the SCP with the low literacy educational supplement.
II. To quantify the potential benefit of tailoring the care plan and the educational supplement.
III. Compare providers' assessment of patients':
IIIa. Health literacy; IIIb. Comprehension of survivorship care recommendations; IIIc. Understanding of long term and late effects from treatment; IIId. To measures obtained from patients.
OUTLINE: Patients are randomized to 1 of 2 groups.
GROUP I (INTERVENTION): Patients receive standard SCP during a provider visit and a tailored SCP with a low literacy educational supplement during a structured interview over 30-60 minutes.
GROUP II (CONTROL): Patients receive standard SCP using the prostate cancer ASCO template during a provider visit and undergo a structured interview over 30-60 minutes.
연구 유형
등록 (추정된)
단계
- 해당 없음
연락처 및 위치
연구 연락처
- 이름: Kerry L. Kilbridge, MD, MSc
- 전화번호: 617-632-2429
- 이메일: Kerry_Kilbridge@DFCI.HARVARD.EDU
연구 장소
-
-
Georgia
-
Atlanta, Georgia, 미국, 30322
- 모병
- Emory University Hospital/Winship Cancer Institute
-
연락하다:
- Sierra Williams
- 전화번호: 404-778-4898
- 이메일: sierra.williams@emory.edu
-
수석 연구원:
- Viraj Master, MD, PhD, FACS
-
Atlanta, Georgia, 미국, 30303
- 모병
- Grady Memorial Hospital
-
연락하다:
- Sierra Williams
- 전화번호: 404-778-4729
- 이메일: sierra.williams@emory.edu
-
수석 연구원:
- Viraj Master, MD, PhD, FACS
-
Atlanta, Georgia, 미국, 30329
- 모병
- Atlanta VA Medical Center
-
연락하다:
- Sierra Williams
- 전화번호: 404-778-4729
- 이메일: sierra.williams@emory.edu
-
수석 연구원:
- Mohammad Hajiha, MD
-
-
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
설명
Inclusion Criteria:
- Black and African American men who are disease-free after completing primary surgery and/or radiation treatment for localized or oligometastatic prostate cancer between 1 to 4 years prior to enrollment. (Race/ethnicity per medical records and self report)
- Patients who are still receiving adjuvant androgen deprivation therapy following primary radiation with non-palliative intent may be included
Exclusion Criteria:
- Dementia or cognitive impairment per provider clinical assessment
- Unable to give informed consent in the judgement of the patient's oncology provider
- Recurrent prostate cancer after primary treatment
- Less than 18 years of age at the time of informed consent
- Diagnosis of active second malignancy requiring treatment
- Individuals who are not able to clearly understand English since the outcome measures require understanding of English
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 지지 요법
- 할당: 무작위
- 중재 모델: 병렬 할당
- 마스킹: 없음(오픈 라벨)
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
|---|---|
|
실험적: Group I (standard SCP, tailored SCP)
Patients receive standard SCP during a provider visit and a tailored SCP with a low literacy educational supplement during a structured interview over 30-60 minutes. |
Ancillary studies Receive a low literacy educational supplement
다른 이름들:
Undergo a structured interview Receive standard SCP
다른 이름들:
Receive a tailored SCP
다른 이름들:
|
|
활성 비교기: Group II (standard SCP)
Patients receive standard SCP using the prostate cancer ASCO template during a provider visit and undergo a structured interview over 30-60 minutes. |
Ancillary studies Undergo a structured interview Receive standard SCP
다른 이름들:
Receive a tailored SCP
다른 이름들:
|
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Comprehension of survivorship care recommendations and prostate specific antigen surveillance
기간: At baseline and up to 3 month phone call
|
Comprehension will be scored as dichotomous variables, correct or incorrect. The proportion of patients who correctly understand after the standard survivorship care plan (SCP) compared to the proportion who correctly understand after the standard SCP + tailoring + educational support will be analyzed using a two-tailed Z-score test for equality of two proportions at a significance level of P < 0.05. |
At baseline and up to 3 month phone call
|
|
Comprehension of treatment side effects and late effects
기간: At baseline and up to 3 month phone call
|
Comprehension will be scored as dichotomous variables, correct or incorrect. The proportion of patients who correctly understand after the standard SCP compared to the proportion who correctly understand after the standard SCP + tailoring + educational support will be analyzed using a two-tailed Z-score test for equality of two proportions at a significance level of P < 0.05. |
At baseline and up to 3 month phone call
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Access to survivorship care for late and long-term side effects
기간: At baseline and up to 3 month phone call
|
Will be assessed using the Patients Access Score (PAS). Descriptive statistics will be used to characterize patient access to survivorship care. The difference in mean PAS will be compared between the two arms using a 2 sample t-test. Results will be compared to previous studies, published work, and other historical cohorts. The concordance of urologists' assessment of patients' outcomes with outcomes obtained from patients will be analyzed as the percent of concordant responses, and with unweighted and weighted kappa coefficients. Linear regression models will be used to identify predictors of access to survivorship care. Parsimonious models will be favored due to the relatively small sample size. |
At baseline and up to 3 month phone call
|
|
Decision regret
기간: At baseline and up to 3 month phone call
|
Descriptive statistics will be used to characterize decision regret. Results will be compared to previous studies, published work, and other historical cohorts. The concordance of urologists' assessment of patients' outcomes with outcomes obtained from patients will be analyzed as the percent of concordant responses, and with unweighted and weighted kappa coefficients. Parsimonious models will be favored due to the relatively small sample size. |
At baseline and up to 3 month phone call
|
|
Change in decisional conflict
기간: At baseline and up to 3 month phone call
|
The two-sample t-test will be used to evaluate the change in the average decisional conflict score between patients in the control arm (standard SCP) and patients in the intervention arm (standard SCP + tailoring + educational supplement). |
At baseline and up to 3 month phone call
|
|
Preparedness for survivorship
기간: At baseline and up to 3 month phone call
|
Descriptive statistics will be used to characterize preparedness for survivorship. Results will be compared to previous studies, published work, and other historical cohorts. The concordance of urologists' assessment of patients' outcomes with outcomes obtained from patients will be analyzed as the percent of concordant responses, and with unweighted and weighted kappa coefficients. Parsimonious models will be favored due to the relatively small sample size. |
At baseline and up to 3 month phone call
|
|
Patient self-efficacy
기간: At baseline and up to 3 month phone call
|
Descriptive statistics will be used to characterize patient self-efficacy. Results will be compared to previous studies, published work, and other historical cohorts. The concordance of urologists' assessment of patients' outcomes with outcomes obtained from patients will be analyzed as the percent of concordant responses, and with unweighted and weighted kappa coefficients. Parsimonious models will be favored due to the relatively small sample size. |
At baseline and up to 3 month phone call
|
공동 작업자 및 조사자
스폰서
수사관
- 수석 연구원: Viraj Master, MD, PhD, FACS, Emory University Hospital/Winship Cancer Institute
연구 기록 날짜
연구 주요 날짜
연구 시작 (실제)
기본 완료 (추정된)
연구 완료 (추정된)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
추가 관련 MeSH 약관
기타 연구 ID 번호
- STUDY00008365
- P30CA138292 (미국 NIH 보조금/계약)
- STUDY00008365 (기타 식별자: Emory University Hospital/Winship Cancer Institute)
- NCI-2024-08650 (레지스트리 식별자: CTRP (Clinical Trial Reporting Program))
- WINSHIP6368-24 (기타 식별자: Emory University Hospital/Winship Cancer Institute)
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
미국 FDA 규제 기기 제품 연구
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .